[Recurrent diffuse alveolar hemorrhage in systemic lupus erytematosus treated with rituximab and immunoglobulins].
Identifieur interne : 000217 ( PubMed/Checkpoint ); précédent : 000216; suivant : 000218[Recurrent diffuse alveolar hemorrhage in systemic lupus erytematosus treated with rituximab and immunoglobulins].
Auteurs : Águeda Prior-Espa Ol [Espagne] ; Melania Martínez-Morillo [Espagne] ; Anne Riveros-Frutos [Espagne] ; Alejandro Olivé [Espagne]Source :
- Medicina clinica [ 1578-8989 ] ; 2015.
Descripteurs français
- KwdFr :
- Association de médicaments, Cyclophosphamide (usage thérapeutique), Humains, Hydroxychloroquine (usage thérapeutique), Hémorragie (étiologie), Immunoglobulines par voie veineuse (usage thérapeutique), Immunosuppresseurs (usage thérapeutique), Induction de rémission, Jeune adulte, Lupus érythémateux disséminé (), Lupus érythémateux disséminé (traitement médicamenteux), Maladies pulmonaires (étiologie), Mâle, Méthylprednisolone (usage thérapeutique), Prednisone (usage thérapeutique), Rituximab (usage thérapeutique), Récidive.
- MESH :
- traitement médicamenteux : Lupus érythémateux disséminé.
- usage thérapeutique : Cyclophosphamide, Hydroxychloroquine, Immunoglobulines par voie veineuse, Immunosuppresseurs, Méthylprednisolone, Prednisone, Rituximab.
- étiologie : Hémorragie, Maladies pulmonaires.
- Association de médicaments, Humains, Induction de rémission, Jeune adulte, Lupus érythémateux disséminé, Mâle, Récidive.
English descriptors
- KwdEn :
- Cyclophosphamide (therapeutic use), Drug Therapy, Combination, Hemorrhage (etiology), Humans, Hydroxychloroquine (therapeutic use), Immunoglobulins, Intravenous (therapeutic use), Immunosuppressive Agents (therapeutic use), Lung Diseases (etiology), Lupus Erythematosus, Systemic (complications), Lupus Erythematosus, Systemic (drug therapy), Male, Methylprednisolone (therapeutic use), Prednisone (therapeutic use), Recurrence, Remission Induction, Rituximab (therapeutic use), Young Adult.
- MESH :
- chemical , therapeutic use : Cyclophosphamide, Hydroxychloroquine, Immunoglobulins, Intravenous, Immunosuppressive Agents, Methylprednisolone, Prednisone, Rituximab.
- complications : Lupus Erythematosus, Systemic.
- drug therapy : Lupus Erythematosus, Systemic.
- etiology : Hemorrhage, Lung Diseases.
- Drug Therapy, Combination, Humans, Male, Recurrence, Remission Induction, Young Adult.
DOI: 10.1016/j.medcli.2015.02.007
PubMed: 25858768
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:25858768Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Recurrent diffuse alveolar hemorrhage in systemic lupus erytematosus treated with rituximab and immunoglobulins].</title>
<author><name sortKey="Prior Espa Ol, Agueda" sort="Prior Espa Ol, Agueda" uniqKey="Prior Espa Ol A" first="Águeda" last="Prior-Espa Ol">Águeda Prior-Espa Ol</name>
<affiliation wicri:level="3"><nlm:affiliation>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona, España. Electronic address: agueda_88@hotmail.com.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Martinez Morillo, Melania" sort="Martinez Morillo, Melania" uniqKey="Martinez Morillo M" first="Melania" last="Martínez-Morillo">Melania Martínez-Morillo</name>
<affiliation wicri:level="3"><nlm:affiliation>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Riveros Frutos, Anne" sort="Riveros Frutos, Anne" uniqKey="Riveros Frutos A" first="Anne" last="Riveros-Frutos">Anne Riveros-Frutos</name>
<affiliation wicri:level="3"><nlm:affiliation>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Olive, Alejandro" sort="Olive, Alejandro" uniqKey="Olive A" first="Alejandro" last="Olivé">Alejandro Olivé</name>
<affiliation wicri:level="3"><nlm:affiliation>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25858768</idno>
<idno type="pmid">25858768</idno>
<idno type="doi">10.1016/j.medcli.2015.02.007</idno>
<idno type="wicri:Area/PubMed/Corpus">000260</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000260</idno>
<idno type="wicri:Area/PubMed/Curation">000260</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000260</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000217</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000217</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Recurrent diffuse alveolar hemorrhage in systemic lupus erytematosus treated with rituximab and immunoglobulins].</title>
<author><name sortKey="Prior Espa Ol, Agueda" sort="Prior Espa Ol, Agueda" uniqKey="Prior Espa Ol A" first="Águeda" last="Prior-Espa Ol">Águeda Prior-Espa Ol</name>
<affiliation wicri:level="3"><nlm:affiliation>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona, España. Electronic address: agueda_88@hotmail.com.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Martinez Morillo, Melania" sort="Martinez Morillo, Melania" uniqKey="Martinez Morillo M" first="Melania" last="Martínez-Morillo">Melania Martínez-Morillo</name>
<affiliation wicri:level="3"><nlm:affiliation>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Riveros Frutos, Anne" sort="Riveros Frutos, Anne" uniqKey="Riveros Frutos A" first="Anne" last="Riveros-Frutos">Anne Riveros-Frutos</name>
<affiliation wicri:level="3"><nlm:affiliation>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Olive, Alejandro" sort="Olive, Alejandro" uniqKey="Olive A" first="Alejandro" last="Olivé">Alejandro Olivé</name>
<affiliation wicri:level="3"><nlm:affiliation>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Medicina clinica</title>
<idno type="eISSN">1578-8989</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cyclophosphamide (therapeutic use)</term>
<term>Drug Therapy, Combination</term>
<term>Hemorrhage (etiology)</term>
<term>Humans</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Immunoglobulins, Intravenous (therapeutic use)</term>
<term>Immunosuppressive Agents (therapeutic use)</term>
<term>Lung Diseases (etiology)</term>
<term>Lupus Erythematosus, Systemic (complications)</term>
<term>Lupus Erythematosus, Systemic (drug therapy)</term>
<term>Male</term>
<term>Methylprednisolone (therapeutic use)</term>
<term>Prednisone (therapeutic use)</term>
<term>Recurrence</term>
<term>Remission Induction</term>
<term>Rituximab (therapeutic use)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Association de médicaments</term>
<term>Cyclophosphamide (usage thérapeutique)</term>
<term>Humains</term>
<term>Hydroxychloroquine (usage thérapeutique)</term>
<term>Hémorragie (étiologie)</term>
<term>Immunoglobulines par voie veineuse (usage thérapeutique)</term>
<term>Immunosuppresseurs (usage thérapeutique)</term>
<term>Induction de rémission</term>
<term>Jeune adulte</term>
<term>Lupus érythémateux disséminé ()</term>
<term>Lupus érythémateux disséminé (traitement médicamenteux)</term>
<term>Maladies pulmonaires (étiologie)</term>
<term>Mâle</term>
<term>Méthylprednisolone (usage thérapeutique)</term>
<term>Prednisone (usage thérapeutique)</term>
<term>Rituximab (usage thérapeutique)</term>
<term>Récidive</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Cyclophosphamide</term>
<term>Hydroxychloroquine</term>
<term>Immunoglobulins, Intravenous</term>
<term>Immunosuppressive Agents</term>
<term>Methylprednisolone</term>
<term>Prednisone</term>
<term>Rituximab</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Lupus Erythematosus, Systemic</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lupus Erythematosus, Systemic</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Hemorrhage</term>
<term>Lung Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Lupus érythémateux disséminé</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Cyclophosphamide</term>
<term>Hydroxychloroquine</term>
<term>Immunoglobulines par voie veineuse</term>
<term>Immunosuppresseurs</term>
<term>Méthylprednisolone</term>
<term>Prednisone</term>
<term>Rituximab</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Hémorragie</term>
<term>Maladies pulmonaires</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Therapy, Combination</term>
<term>Humans</term>
<term>Male</term>
<term>Recurrence</term>
<term>Remission Induction</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Association de médicaments</term>
<term>Humains</term>
<term>Induction de rémission</term>
<term>Jeune adulte</term>
<term>Lupus érythémateux disséminé</term>
<term>Mâle</term>
<term>Récidive</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25858768</PMID>
<DateCompleted><Year>2016</Year>
<Month>09</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>11</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-8989</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>145</Volume>
<Issue>11</Issue>
<PubDate><Year>2015</Year>
<Month>Dec</Month>
<Day>07</Day>
</PubDate>
</JournalIssue>
<Title>Medicina clinica</Title>
<ISOAbbreviation>Med Clin (Barc)</ISOAbbreviation>
</Journal>
<ArticleTitle>[Recurrent diffuse alveolar hemorrhage in systemic lupus erytematosus treated with rituximab and immunoglobulins].</ArticleTitle>
<Pagination><MedlinePgn>507-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.medcli.2015.02.007</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0025-7753(15)00108-6</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prior-Español</LastName>
<ForeName>Águeda</ForeName>
<Initials>Á</Initials>
<AffiliationInfo><Affiliation>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona, España. Electronic address: agueda_88@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Martínez-Morillo</LastName>
<ForeName>Melania</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona, España.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Riveros-Frutos</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona, España.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Olivé</LastName>
<ForeName>Alejandro</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona, España.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>spa</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<VernacularTitle>Tratamiento con rituximab e inmunoglobulinas en la hemorragia alveolar difusa recurrente en lupus eritematoso sistémico.</VernacularTitle>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>04</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Spain</Country>
<MedlineTA>Med Clin (Barc)</MedlineTA>
<NlmUniqueID>0376377</NlmUniqueID>
<ISSNLinking>0025-7753</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4F4X42SYQ6</RegistryNumber>
<NameOfSubstance UI="D000069283">Rituximab</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>8N3DW7272P</RegistryNumber>
<NameOfSubstance UI="D003520">Cyclophosphamide</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>VB0R961HZT</RegistryNumber>
<NameOfSubstance UI="D011241">Prednisone</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>X4W7ZR7023</RegistryNumber>
<NameOfSubstance UI="D008775">Methylprednisolone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D003520" MajorTopicYN="N">Cyclophosphamide</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016756" MajorTopicYN="N">Immunoglobulins, Intravenous</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008775" MajorTopicYN="N">Methylprednisolone</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011241" MajorTopicYN="N">Prednisone</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012074" MajorTopicYN="N">Remission Induction</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000069283" MajorTopicYN="N">Rituximab</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year>
<Month>02</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2015</Year>
<Month>02</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>4</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>4</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>9</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25858768</ArticleId>
<ArticleId IdType="pii">S0025-7753(15)00108-6</ArticleId>
<ArticleId IdType="doi">10.1016/j.medcli.2015.02.007</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
</country>
<region><li>Catalogne</li>
</region>
<settlement><li>Barcelone</li>
</settlement>
</list>
<tree><country name="Espagne"><region name="Catalogne"><name sortKey="Prior Espa Ol, Agueda" sort="Prior Espa Ol, Agueda" uniqKey="Prior Espa Ol A" first="Águeda" last="Prior-Espa Ol">Águeda Prior-Espa Ol</name>
</region>
<name sortKey="Martinez Morillo, Melania" sort="Martinez Morillo, Melania" uniqKey="Martinez Morillo M" first="Melania" last="Martínez-Morillo">Melania Martínez-Morillo</name>
<name sortKey="Olive, Alejandro" sort="Olive, Alejandro" uniqKey="Olive A" first="Alejandro" last="Olivé">Alejandro Olivé</name>
<name sortKey="Riveros Frutos, Anne" sort="Riveros Frutos, Anne" uniqKey="Riveros Frutos A" first="Anne" last="Riveros-Frutos">Anne Riveros-Frutos</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000217 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000217 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:25858768 |texte= [Recurrent diffuse alveolar hemorrhage in systemic lupus erytematosus treated with rituximab and immunoglobulins]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:25858768" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a ChloroquineV1
This area was generated with Dilib version V0.6.33. |